Cannabis Vape Safety – Berkeley Patients Group Statement

September 11th, 2019

As various news outlets have reported, a growing number of reports surrounding an unidentified vaping related illness has created a serious public health concern with more questions than answers.

Berkeley Patients Group (BPG) has been dedicated to providing safe, clean, quality-controlled cannabis for 20 years. We have always prioritized responsible sourcing and have established long-term partnerships with providers that exceed mandated quality standards. It is why we pioneered the development of cannabis testing standards over ten years ago.

To date, we are not aware of any respiratory-related illness caused by a product sold at BPG or any other licensed California dispensary. While there are many unknowns at this time, BPG is using every resource at our disposal to promote consumer safety and to provide timely information.

 

ACTIONS WE ARE TAKING:

· Contacting every vape cartridge vendor to verify problematic, questionable additives or parts are not in any products we sell

· Staying up-to-date with the latest information and research on this issue. BPG will issue periodic updates as information is released from authorities

· Sourcing products tested according to state guidelines

· Verifying testing certificates as genuine and battery devices are not inhalation-activated

 

WHAT WE KNOW:

· An increasing number of vaping-related illnesses, approximately 800 cases, including thirteen deaths have been reported across 33 states to date, including California.

· All of the California-related illnesses were caused by products purchased in the unlicensed market.

· No single device, ingredient or additive has been identified as the sole cause of this mysterious epidemic.

· Many of the associated products contain THC, some contain nicotine, and some include both.

· Symptoms: Patients are coming into hospitals with cough, chest pain, shortness of breath, fatigue and vomiting.

· Colorado Green Lab recently conducted a vape pen study and posted key findings associated with inhalation-activated vape battery devices

 

EMERGING INFORMATION:

· Doctors suspect the cause may be chemical exposure related to additives or ingredients, such as Vitamin E acetate.

 

Our hearts go out to the victims and the loved ones of those who are currently suffering or have succumbed to this devastating illness.

This crisis further shows the immediate need for federal reform that will enable proper research, regulations, and guaranteed product safety and efficacy for patients. Eliminating illicit operators and the entities providing a public platform to them should be the number one priority for the State of California and the nation.

We are encouraging any BPG customers who experience any problems or have additional questions regarding vape products sold by BPG, to email us at info@mybpg.com.

 

Further information is available from NORML online herehere, and here. California NORML’s fact-sheet, “Cannabis Vaping: What’s Safe and What’s Not,” is online here. An advisory by Leafly.com, entitled “Vape Pen Lung Disease: Here’s What You Need to Know,” is online here. An advisory from the City of Berkeley is online here.

 

heart Your Buds at BPG

Memorial Day at Berkeley Patients Group

May 23rd, 2019

Memorial Day at BPG

As we take a moment to remember those who made the ultimate sacrifice for our country, we also look towards the future for our fellow Americans who served and returned home.

Owner and Vice President of Berkeley Patients Group, Etienne Fontan, spent time in DC this week advocating for the fair and equal treatment of all cannabis patients, consumers, and businesses with the National Cannabis Industry Association. Read more »

4/20 for 20 Years!

April 11th, 2019

A Historic 4/20 Celebration

As the nation’s longest-running dispensary, we’ve been celebrating the 4/20 holiday for quite some time. This year is extremely special to us, as it’s our 20th anniversary — 4/20 for TWENTY YEARS! We hope you will join us for this year’s community event.

BPG Celebrates 4/20 for 20 Years

Read more »

The DEA Just Placed a Marijuana-Derived Drug In Schedule V

September 27th, 2018

This story originally appeared on MarijuanaMoment.net.

The Drug Enforcement Administration (DEA) placed a marijuana-derived drug in Schedule V of the Controlled Substances Act on Thursday.

The medication, Epidiolex, contains purified cannabidiol (CBD), a non-psychoactive ingredient in cannabis. It was approved as a treatment option for severe forms of epilepsy by the Food and Drug Administration (FDA) in June.

Read more »

Feds Would Compile Tips For Growing Marijuana Under Proposal Advancing In Congress

September 18th, 2018

This story was originally published on MarijuanaMoment.net.

A key congressional committee approved a bill last week that would require the Department of Justice to issue more licenses for people to grow marijuana for research. But lost in the excitement about the historic vote, a little-noticed amendment got attached to the legislation that would have additional surprising impacts for cannabis policy.

The provision directs federal agencies to compile a list of “good manufacturing practices for growing and producing marijuana.”

Read more »